ATC Group: H01BA02 Desmopressin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of H01BA02 in the ATC hierarchy

Level Code Title
1 H Systemic hormonal preparations, excl. Sex hormones and insulins
2 H01 Pituitary and hypothalamic hormones and analogues
3 H01B Posterior pituitary lobe hormones
4 H01BA Vasopressin and analogues
5 H01BA02 Desmopressin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
NASAL - Nasal 25 ug
ORAL - Oral 0.4 mg
PAREN - Parenteral 4 ug
SL - Sublingual 0.24 mg

Active ingredients in H01BA02

Active Ingredient Description
Desmopressin

Desmopressin is a structural analogue of vasopressin in which the antidiuretic activity has been enhanced by the order of 10, while the vasopressor effect has been reduced by the order of 1500. The clinical advantage of this highly changed ratio of antidiuretic to vasopressor effect is that clinically active antidiuretic doses are far below the threshold for a vasopressor effect.

Related product monographs

Title Information Source Document Type  
DDAVP DESMOPRESSIN Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DDAVP MELT Oral lyophilisate Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DESMOSPRAY Nasal spray, solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
DESMOTABS Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NOCDURNA Orally disintegrating tablet Health Products and Food Branch (CA) MPI, CA: SPM
OCTIM Nasal spray Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
OCTOSTIM Solution for injection Health Products and Food Branch (CA) MPI, CA: SPM

Medicines in this ATC group

United States (US)

Australia (AU)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Israel (IL)

Japan (JP)

Lithuania (LT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.